Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THAM vs Sodium Bicarbonate in Cardiac Surgical Patients
NCT07424625Phase 4Recruiting
- Sponsor
- Mayo Clinic
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in metabolic acidosis, sponsored by Mayo Clinic. Primary endpoint: Change in pH following buffer administration at 2 hours. Started Sep 2026; status: recruiting.
02
Conditions
metabolic acidosis
Beyond the preview
Go deeper on NCT07424625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07424625.